Navamedic ASA: Minutes of Extraordinary General Meeting

Oslo, 7 January 2026: The announced extraordinary general meeting of NavamedicASA ("Navamedic" or the "Company", OSE ticker: "NAVA") was held today at 12:00CET. All items on the agenda were approved in accordance with the board ofdirectors' proposals and the nomination committee's recommendations. A copy ofthe minutes from the extraordinary general meeting is attached to this noticeand will also be made available on the Company's webpage www.navamedic.com.This information is …

Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg

Grete Roede og Navamedic inngår et samarbeid om en ny, strukturert metode forvektreduksjon. Det første konseptet, Lettere steg, lanseres i romjulen 2025 ogfortsetter inn i 2026. Konseptet legger vekt på fellesskap, støtte ogerfaringsdeling underveis i prosessen.Hele Norges «slankedronning» Grete Roede grunnla selskapet for å hjelpe nordmennmed å få kontroll over vekten. I dag ledes selskapet av datteren Jeanette Roedeog tilbyr personlig veiledning, kurs og digitale løsninger …

NAVA: Financial calendar

Financial calendar for Navamedic ASAFINANCIAL YEAR 202512.02.2026 - Quarterly Report - Q4FINANCIAL YEAR 202619.08.2026 - Half-yearly Report25.03.2026 - Annual Report24.04.2026 - Annual General Meeting24.04.2026 - Quarterly Report - Q129.10.2026 - Quarterly Report - Q3This information is published pursuant to the requirements set out in theContinuing obligations.

Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026

Oslo, 12 December 2025: Navamedic ASA ("Navamedic" or the "Company", OSE ticker:"NAVA") hereby announces that an extraordinary general meeting of Navamedic willbe held on 7 January 2026 at 12:00 CET in order to amend the composition of theboard of directors of the Company.The extraordinary general meeting of the Company will be held at the Company'soffices at Henrik Ibsens gate 100, 0255 Oslo, Norway. Registration of attendancemust be received no later than 5 January 2026 at …

Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026

Navamedic ASA Launches Flexilev in OraFID for Enhanced Parkinson's Treatment

(AWP Alliance News) - Navamedic ASA has announced the launch of Flexilev(R) in OraFID(R), a novel single-use dosing dispenser designed to deliver precise and personalized treatment for Parkinson's disease. The product will be available for prescription at pharmacies in late December or early January. This initiative reflects Navamedic's ongoing efforts to expand its portfolio and enhance its impact in the healthcare sector, particularly through innovative healthcare solutions…

Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment

Navamedic ASA is excited to announce the launch of Flexilev[®] in OraFID[®], anovel, single-use dosing dispenser specifically designed to deliver precise andpersonalized Parkinson's treatment in a user-friendly format. The product willbe available for prescription at pharmacies late December/early January.As Parkinson's disease advances, patients frequently experience variations inmotor abilities throughout the day. For those facing reduced efficacy towardsthe end of the dosi…

Navamedic Names New Finance Chief

02:09 AM EST, 12/08/2025 (MT Newswires) -- Nordic pharmaceutical company Navamedic (NAVA.OL) appointed Nils Ole Krekling as its chief financial officer, effective Jan. 1, 2026. Krekling serves as group vice president, corporate development, and head of mergers and acquisitions of Norwegian technology company Kongsberg Gruppen (KOG.OL), according to a Monday release.

Navamedic ASA Appoints Nils Ole Krekling as CFO

(AWP Alliance News) - Navamedic ASA has appointed Nils Ole Krekling as Chief Financial Officer, effective January 1, 2026. Krekling joins the company from Kongsberg Gruppen ASA, where he served as Group VP Corporate Development and Head of M&A. http://publish.ne.cision.com//Release/ViewReleaseHtml/7A162A7572867716E0C856B0705FC7D6 Disclaimer: This news brief was created using generative artificial intelligence. Navamedic ASA published the original content used to generate this…

Navamedic ASA: Appointment of CFO

Oslo, 8 December 2025: Navamedic ASA ("Navamedic" or the "Company", OSE ticker:"NAVA") is pleased to announce that the Company has appointed Nils Ole KreklingChief Financial Officer (CFO) of Navamedic ASA, effective 1 January 2026.Mr. Krekling joins Navamedic from Kongsberg Gruppen ASA, where he currentlyserves as Group VP Corporate Development and Head of M&A."With extensive experience from both finance and strategy roles, Mr. Kreklingbrings valuable expertise that will stre…

Navamedic ASA: Utnevnelse av Finansdirektør

Oslo, 8. desember 2025: Navamedic ASA ("Navamedic" eller "Selskapet", OSE-ticker: "NAVA") har gleden av å kunngjøre at selskapet har utnevnt Nils OleKrekling til Finansdirektør i Navamedic ASA, med virkning fra 1. januar 2026.Krekling kommer fra Kongsberg Gruppen ASA, hvor han i dag har rollen som GroupVP Corporate Development og leder for M&A.«Med sin omfattende erfaring innen både finans og strategiske roller, tilførerKrekling verdifull kompetanse som vil styrke vår finansi…

Navamedic ASA: Utnevnelse av Finansdirektør

Navamedic ASA: Appointment of CFO

Pharmaceutical Company Navamedic's CFO Steps Down

12:09 PM EST, 11/28/2025 (MT Newswires) -- Navamedic (NAVA.OL) said Friday that Lars Hjarrand will step down as chief financial officer to take on new opportunities outside the company. The Nordic pharmaceutical group appointed its director of group accounting, Pål Zimmermann Vonen, as interim CFO until a permanent successor is named.

Navamedic ASA CFO Lars Hjarrand Resigns

(AWP Alliance News) - Navamedic ASA announced that CFO Lars Hjarrand will step down to pursue new opportunities outside the company. Pål Zimmermann Vonen, Director of Group Accounting, will serve as acting CFO until a permanent replacement is appointed. http://publish.ne.cision.com//Release/ViewReleaseHtml/1653CB94C741922FE0C856B0705FC7D6 Disclaimer: This news brief was created using generative artificial intelligence. Navamedic ASA published the original content used to gene…

Navamedic ASA: Resignation of CFO

Oslo, 28 November 2025: Navamedic ASA ("Navamedic" or the "Company", OSE ticker:"NAVA") announces that the Company and its Chief Financial Officer (CFO), LarsHjarrand, today has entered into an agreement whereby Hjarrand will step down asCFO of the Company to pursue new opportunities outside the Company. Director ofGroup Accounting, Pål Zimmermann Vonen will assume the role as acting CFO untila new permanent CFO has been appointed."We wish to express our gratitude to Lars for…

Navamedic ASA: Resignation of CFO

Navamedic · 2024 financial report

Navamedic · 2024-Q3 financial report

Navamedic · 2024-Q2 financial report

Navamedic · 2024-Q1 financial report